Entity Common Stock, Shares Outstanding of Arcus Biosciences, Inc. from 01 May 2018 to 23 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Arcus Biosciences, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 May 2018 to 23 Oct 2025.
  • Arcus Biosciences, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 23 Oct 2025 was 107,973,536, a 18% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Arcus Biosciences, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 107,973,536 +16,461,927 +18% 23 Oct 2025 10-Q 28 Oct 2025 2025 Q3
Q2 2025 106,430,976 +15,003,471 +16% 01 Aug 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 105,885,138 +14,932,127 +16% 01 May 2025 10-Q 06 May 2025 2025 Q1
Q3 2024 91,511,609 +16,656,044 +22% 30 Oct 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 91,427,505 +16,923,841 +23% 01 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 90,953,011 +17,847,431 +24% 01 May 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 90,864,829 14 Feb 2024 10-K 21 Feb 2024 2023 FY
Q3 2023 74,855,565 +2,447,859 +3.4% 01 Nov 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 74,503,664 +2,343,702 +3.2% 02 Aug 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 73,105,580 +1,387,016 +1.9% 03 May 2023 10-Q 09 May 2023 2023 Q1
Q3 2022 72,407,706 +2,158,231 +3.1% 28 Oct 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 72,159,962 +765,925 +1.1% 29 Jul 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 71,718,564 +722,704 +1% 29 Apr 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 71,061,867 +185,645 +0.26% 12 Feb 2022 10-K 23 Feb 2022 2021 FY
Q3 2021 70,249,475 +5,326,171 +8.2% 29 Oct 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 71,394,037 +6,487,709 +10% 30 Jul 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 70,995,860 +24,949,834 +54% 30 Apr 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 70,876,222 12 Feb 2021 10-K 25 Feb 2021 2020 FY
Q3 2020 64,923,304 +19,064,328 +42% 31 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 64,906,328 +19,057,139 +42% 31 Jul 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 46,046,026 +1,510,991 +3.4% 30 Apr 2020 10-Q 05 May 2020 2020 Q1
Q3 2019 45,858,976 +1,405,252 +3.2% 30 Oct 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 45,849,189 +1,392,530 +3.1% 30 Jul 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 44,535,035 +80,760 +0.18% 29 Apr 2019 10-Q 02 May 2019 2019 Q1
Q3 2018 44,453,724 01 Nov 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 44,456,659 01 Aug 2018 10-Q 06 Aug 2018 2018 Q2
Q1 2018 44,454,275 01 May 2018 10-Q 09 May 2018 2018 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.